|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
XRP Dominance Has Edged Close to a Critical Level
Mar 16, 2025 at 08:00 am
In a recent X post Egrag Crypto shared his views and forecasted that XRP dominance could well close at more than 6%, the 2021 high.

Egrag Crypto, a renowned cryptocurrency analyst, shared his optimistic outlook on XRP's dominance, highlighting a critical Fibonacci level that could propel the digital asset toward a significant milestone.
In a recent X post, Egrag noted that XRP dominance is poised to close above the 2021 high of 6%, Moreover, it's nearing the Fibonacci 0.5 level, which he considers a crucial point of distinction. According to him, if XRP manages to close above this Fib 0.5, it could potentially surge toward the next Fibonacci level of 0.888.
This move would bring XRP closer to the goal of achieving between 15-20% market dominance from its current position.
"If #XRP dominance manages to close above Fib 0.5, we can expect a continuation towards Fib 0.888, aiming for a 15-20% market dominance from its current position. This would also place #XRP in close proximity to the 2015 highs, which I believe are within reach in the bigger picture.
The fact that we're discussing Fib 0.5 and 0.888 levels signifies a continued expansion of the token's utilization within the crypto industry, ultimately leading to increased demand and attention on the asset.
However, this analysis within the technical field is heating up as we approach the apex of the market.
The market is still in a bullish mood as many tokens have shown an increase in value. For instance, at the moment, network token has 31% dominance, which could be viewed as a starting point for developing its market share.
The rates higher than the Fibonacci 0.5 level are not just an analysis within technical field. This would further solidify the continued expansion of utilization of token in the crypto industry. It could lead to increased demand and focus on the asset.
At the time of writing, token is trading at $2.42, which has increased by 4.98% within the past day. Looking at the all-time highs of 2015, such proximity to the 15-20% dominance range would justify token’s equality to such previous highs according to Egrag. Such a move would be landmark for the cryptocurrency and prove that it still has its place in the international financial market.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































